SAG
ABVX

SageView Advisory Group’s Abivax ABVX Stock Holding History

SageView Advisory Group’s Portfolio ABVX Stock Details ABVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$5.53K Buy
+41
New +$4.47K ﹤0.01% 1940

Other funds holding ABVX

TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

SageView Advisory Group's ABVX Position: Q4 2025 in Review

SageView Advisory Group opened a new position in Abivax (ABVX) in Q4 2025: 41 shares worth $5.53K. The stake represents ﹤0.01% of the portfolio and ranks #1940 among its holdings.

247 funds tracked by Wall St. Rank hold ABVX as of Q4 2025.

  • SageView Advisory Group held 41 shares of Abivax worth $5.53K as of Q4 2025.
  • Abivax was a new SageView Advisory Group position in Q4 2025.
  • Abivax made up ﹤0.01% of SageView Advisory Group's portfolio in Q4 2025, its #1940 holding.
  • 247 funds tracked by Wall St. Rank held Abivax as of Q4 2025.

Based on SageView Advisory Group's 13F filing for Q4 2025, filed 17 Feb 2026.